CEO, Professor
Rikard Holmdahl has more than 40 years experience mainly from academic research but also from business activities as founder, board member and member of scientific advisory boards for venture capital and biopharma companies. He made his MD and PhD at Uppsala University in 1987, professor in 1994 at Lund University and in 2008 at Karolinska Institute, and is currently leading research groups as guest professor in Uppsala University and Xi'an Jiaotong University. He has served for many years in the Nobel assembly and as an adjunct member in the Nobel Committee for Medicine or Physiology. He has more than 600 publications in peer-reviewed academic journals. Holmdahl is, or has been, the co-founder of Arexis, Redoxis, Pronoxis and a scientific advisor for Bankinvest, Hansa Medical, Oxypharma, Cyxone, Lipum.
Rikard Holmdahl is the founder of Vacara.
